Elucidating the molecular mechanisms associated with TARS2-related mitochondrial disease.


Journal

Human molecular genetics
ISSN: 1460-2083
Titre abrégé: Hum Mol Genet
Pays: England
ID NLM: 9208958

Informations de publication

Date de publication:
21 02 2022
Historique:
received: 23 06 2021
revised: 30 08 2021
accepted: 31 08 2021
pubmed: 12 9 2021
medline: 28 4 2022
entrez: 11 9 2021
Statut: ppublish

Résumé

TARS2 encodes human mitochondrial threonyl tRNA-synthetase that is responsible for generating mitochondrial Thr-tRNAThr and clearing mischarged Ser-tRNAThr during mitochondrial translation. Pathogenic variants in TARS2 have hitherto been reported in a pair of siblings and an unrelated patient with an early onset mitochondrial encephalomyopathy and a combined respiratory chain enzyme deficiency in muscle. We here report five additional unrelated patients with TARS2-related mitochondrial diseases, expanding the clinical phenotype to also include epilepsy, dystonia, hyperhidrosis and severe hearing impairment. In addition, we document seven novel TARS2 variants-one nonsense variant and six missense variants-that we demonstrate are pathogenic and causal of the disease presentation based on population frequency, homology modeling and functional studies that show the effects of the pathogenic variants on TARS2 stability and/or function.

Identifiants

pubmed: 34508595
pii: 6367975
doi: 10.1093/hmg/ddab257
doi:

Substances chimiques

RNA, Transfer, Thr 0
Threonine-tRNA Ligase EC 6.1.1.3

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

523-534

Subventions

Organisme : Medical Research Council
ID : G1000848
Pays : United Kingdom
Organisme : European Research Council
ID : 309548
Pays : International
Organisme : Medical Research Council
ID : MR/N025431/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N010035/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N025431/2
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/V009346/1
Pays : United Kingdom

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Auteurs

Wen-Qiang Zheng (WQ)

State Key Laboratory of Molecular Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai 200031, China.
School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China.

Signe Vandal Pedersen (SV)

Department of Clinical Genetics, Copenhagen University Hospital Rigshospitalet, Copenhagen 2100, Denmark.

Kyle Thompson (K)

Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.

Emanuele Bellacchio (E)

Area di Ricerca Genetica e Malattie Rare, Bambino Gesù Children's Hospital, IRCCS, Rome 00165, Italy.

Courtney E French (CE)

Department of Medical Genetics, University of Cambridge, Cambridge CB2 0QQ, UK.

Benjamin Munro (B)

Department of Clinical Neurosciences, John Van Geest Centre for Brain Repair, School of Clinical Medicine, University of Cambridge, Cambridge CB2 0QQ, UK.

Toni S Pearson (TS)

Department of Neurology, Washington University School of Medicine, St. Louis, MO 63110, USA.

Julie Vogt (J)

West Midlands Regional Genetics Service, Birmingham Women's and Children's NHS Foundation Trust, Birmingham Women's Hospital, Birmingham B15 2TG, UK.

Daria Diodato (D)

Neuromuscular and Neurodegenerative Disease Unit, Children Hospital Bambino Gesù, Rome 00165, Italy.

Tue Diemer (T)

Department of Clinical Genetics, Aalborg University Hospital, Aalborg 9000, Denmark.

Anja Ernst (A)

Department of Molecular Diagnostics, Aalborg University Hospital, Aalborg 9000, Denmark.

Rita Horvath (R)

Department of Clinical Neurosciences, John Van Geest Centre for Brain Repair, School of Clinical Medicine, University of Cambridge, Cambridge CB2 0QQ, UK.

Manali Chitre (M)

Department of Paediatric Neurology, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.

Jakob Ek (J)

Department of Clinical Genetics, Copenhagen University Hospital Rigshospitalet, Copenhagen 2100, Denmark.

Flemming Wibrand (F)

Department of Clinical Genetics, Copenhagen University Hospital Rigshospitalet, Copenhagen 2100, Denmark.

Dorothy K Grange (DK)

Department of Pediatrics, Division Genetics and Genomic Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.

Lucy Raymond (L)

Department of Medical Genetics, University of Cambridge, Cambridge CB2 0QQ, UK.

Xiao-Long Zhou (XL)

State Key Laboratory of Molecular Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai 200031, China.

Robert W Taylor (RW)

Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.

Elsebet Ostergaard (E)

Department of Clinical Genetics, Copenhagen University Hospital Rigshospitalet, Copenhagen 2100, Denmark.
Department of Clinical Medicine, University of Copenhagen, Copenhagen 2200, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH